Gating Mechanism for Biased Agonism at Angiotensin II Type 1 Receptors

Area of Science:

• Biochemistry and Molecular Pharmacology
• Cardiovascular Physiology
• Computational Chemistry

Background:

• The interaction between Angiotensin II (AngII) and AngII type 1 receptors (AT1R) is crucial for regulating blood pressure.
• Two distinct proton hopping pathways have been proposed for this interaction, each leading to different signaling cascades.

Purpose of the Study:

• To elucidate the molecular mechanisms underlying AngII-AT1R interactions.
• To investigate the role of the charge relay system (CRS) in mediating distinct physiological responses.
• To provide insights for the development of novel AT1R-targeting therapeutics.

Main Methods:

• Analysis of structure-activity data from AngII analogs.
• Quantum mechanical (semiempirical) calculations of proton transfer within the CRS.
• Examination of G protein and arrestin-mediated signaling pathways.

Main Results:

• A charge relay system (CRS) involving AngII residues (Tyr4, His6) and AT1R residues (D281, K199) was identified.
• One pathway (Tyr4-His6 interaction) promotes G protein signaling, leading to vasoconstriction.
• A second pathway (Tyr4-Phe8 interaction) engages arrestin, causing vasodilation and receptor desensitization.

Conclusions:

• The identified proton hopping pathways and CRS formation act as a gating mechanism for AT1R signaling.
• Understanding these pathways offers a basis for designing targeted AT1R modulators.
• Findings support the therapeutic strategies of current angiotensin receptor blockers (sartans) and the development of next-generation bisartans.